Alnylam Shares Plunge as a Drug Candidate Is Discontinued
Alnylam Pharmaceuticals ’ shares dropped after discontinued development of its rare-disease treatment revusiran following unfavorable clinical trial data. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 5, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Why Watching Silly Cat Videos Is Good for You
A host of new research shows that social media has many positive benefits. Sharing about events can make you remember them, and opening up about feeling down can lead to more support. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 5, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
AstraZeneca's Brilinta Fails Arterial Disease Drug Trial
AstraZeneca cut its sales target for prescription blood-thinning medicine Brilinta after it failed to show a benefit over standard treatment in peripheral artery disease in a large clinical trial. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 5, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
J & J Warns Insulin Pump Vulnerable to Cyber Hacking
Johnson& Johnson has warned diabetes patients and doctors that one of its insulin pumps is vulnerable to cyber hacking. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 5, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Warns on Hepatitis C Drugs
The Food and Drug Administration is warning about the risk of reactivation of hepatitis B among patients who have had that disease and who are taking some prominent and expensive newer medicines for hepatitis C. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 4, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Antitobacco Groups Sue to Require Graphic Labels on Cigarette Packs
Antitobacco groups have filed a lawsuit against the U.S. Food and Drug Administration to push the agency to require graphic warning labels on cigarettes. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 4, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Nobel Prize in Medicine Awarded to Japan's Yoshinori Ohsumi
A Japanese biologist was awarded this year ’s Nobel Prize in Physiology or Medicine for elucidating how the body’s cells deal with and recycle waste, a discovery that has paved the way for research on treatment for neurological and other diseases. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 4, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Samsung BioLogics IPO Could Value Firm at $8.2 Billion
Samsung Group ’s biologic drug manufacturing arm announced fresh details on its plans for a November listing, the same day its subsidiary said it had sought European approval for a near-replica of top-selling cancer drug Herceptin. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 4, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Mylan Tapped for More Information on EpiPen Price Figures
A U.S. House committee sent a letter to Mylan demanding a fuller explanation of why the company omitted key information that it used to calculate the profit figure for the lifesaving EpiPen drug that its chief executive provided during a congressional hearing last month. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 4, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Community Health Systems Adopts Poison Pill
Community Health Systems said it has adopted a poison pill, two weeks after it said it is exploring a deal and as a Chinese billionaire has been building a stake in the company. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 3, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Tenet to Pay $514 Million to Settle Kickback Allegations
Tenet Healthcare said it would pay states and the federal government $514 million to settle allegations that its hospitals in Georgia and South Carolina paid kickbacks for obstetric referrals. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 3, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Drugmakers Point Finger at Middlemen for Rising Drug Prices
As U.S. drug prices rise, drugmakers are playing down their role, instead heaping blame on the middlemen who help determine how medicines are priced. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 3, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Merrimack Pharmaceuticals Cuts Jobs; CEO Resigns
Merrimack Pharmaceuticals said it would slash 22% of its workforce and its chief executive resigned amid a new turnaround plan to accelerate the drugmaker ’s pipeline and shore up its finances. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 3, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Novo Nordisk Bets on Riskier Insulin Research
Danish pharmaceutical company Novo Nordisk is moving into the complex and more expensive business of inventing new forms of insulin, which would bring it closer to the riskier drug-discovery activities of the wider pharmaceutical industry. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 2, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Honest Co. to Drop Disputed Ingredient in Cleaning Products
Jessica Alba ’s Honest Co. is reformulating its laundry detergent and other cleaners, removing an ingredient that has created controversy for the company over its product claims. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 1, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
